SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

High-tech entrepreneur Moshe Yanai’s debts balloon to $250 million

"A Robin Hood movement to help the smaller developers": How Appcharge is fighting app store monopolies

Full list of Israeli high-tech funding rounds in 2026

Israeli startup bets on psychedelic mushrooms for mental health treatment

Buzz

Most popular

Daily

Weekly

1

From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector

2

The 50 most promising Israeli startups - 2026

3

Five bidders advance in Nice’s $2.5 billion Actimize sale process

4

“Israel will remain a cyber powerhouse for the next decade”

5

SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread

Galmed

4 stories about Galmed

Israeli pharmaceutical company Galmed raises $18 million during trial of its main product

22.02.21|James Spiro

The Nasdaq-traded company has developed a drug to treat fatty liver

שרון מלכה MediWound

Biomed at the focus of new Israel-UAE business cooperation

New cross-business initiative is led by Tel-Aviv based consultancy firm Kamir Strategy and UAE-based PR firm Cosmopole

נאסד"ק וול סטריט

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

20.06.18|Dror Reich

Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study

נאסד"ק וול סטריט

Liver Treatment Company Galmed is Raising $6 Million in Direct Offering

04.04.18|Lilach Baumer

The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014